Georgia Defective Drug and Pharmaceutical Recall Lawyer

Not a month goes by without a warning or recall being issued by a company or the FDA regarding a pharmaceutical drug. While some drugs work very effectively for most patients, others are dangerous and have numerous side effects that can cause injury or even death to a patient. Consumers have a right to safe prescription and over-the-counter medications, and also have a right to be told about the risks of drugs they are taking.

Prescription and over-the-counter drugs sold in the United States go through medical trials and are approval by the Food and Drug Administration (FDA). However, often people react to certain medications differently or trials are not conducted adequately.

Grim results may occur when drugs are not tested strenuously enough, and unexpected, or more frequent, side effects become evident once the drug is on the market. Problems can also come up when patients mix certain medications.

The FDA has warned consumers not to buy drugs online, because the sellers may not be licensed and drugs may not be properly labeled or the correct dosage given.

Sadly, some drug companies know the risks involved in the drugs they produce. Others have actually tried to cover up side effects in order to gain FDA approval. Many dangerous drugs result in class action lawsuits against the companies that manufacture them and can reach into the hundreds of millions of dollars.

The pharmaceutical industry is one of the most profitable businesses in the world, with sales that total in the hundreds of billions of dollars annually. Too often, these companies take risks in order to compete with comparable drugs made by other companies.

Therefore, many people take prescriptions, at the advice of their physicians that may have unknown side effects, limited research and testing, and put patients at risk to have disastrous reactions.

Presently, recalled medications continue to dominate the headlines, despite government agency safety regulations.

The Flynn Law Firm is currently involved in litigation related to Yaz, Levaquin and Reglan.